Characterizing ncRNAs in human pathogenic protists using high-throughput sequencing technology

ncRNAs are key genes in many human diseases including cancer and viral infection, as well as providing critical functions in pathogenic organisms such as fungi, bacteria, viruses and protists. Until now the identification and characterization of ncRNAs associated with disease has been slow or inaccu...

Full description

Bibliographic Details
Main Author: Lesley Joan Collins
Format: Article
Language:English
Published: Frontiers Media S.A. 2011-12-01
Series:Frontiers in Genetics
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fgene.2011.00096/full
_version_ 1818253432095506432
author Lesley Joan Collins
author_facet Lesley Joan Collins
author_sort Lesley Joan Collins
collection DOAJ
description ncRNAs are key genes in many human diseases including cancer and viral infection, as well as providing critical functions in pathogenic organisms such as fungi, bacteria, viruses and protists. Until now the identification and characterization of ncRNAs associated with disease has been slow or inaccurate requiring many years of testing to understand complicated RNA and protein gene relationships. High-throughput sequencing now offers the opportunity to characterize miRNAs, siRNAs, snoRNAs and long ncRNAs on a genomic scale making it faster and easier to clarify how these ncRNAs contribute to the disease state. However, this technology is still relatively new, and ncRNA discovery is not an application of high priority for streamlined bioinformatics. Here we summarize background concepts and practical approaches for ncRNA analysis using high-throughput sequencing, and how it relates to understanding human disease. As a case study, we focus on the parasitic protists Giardia lamblia and Trichomonas vaginalis, where large evolutionary distance has meant difficulties in comparing ncRNAs with those from model eukaryotes. A combination of biological, computational and sequencing approaches has enabled easier classification of ncRNA classes such as snoRNAs, but has also aided the identification of novel classes. It is hoped that a higher level of understanding of ncRNA expression and interaction may aid in the development of less harsh treatment for protist-based diseases.
first_indexed 2024-12-12T16:39:58Z
format Article
id doaj.art-296a21bd77ee4b8ea5a08f9d5603bd12
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-12-12T16:39:58Z
publishDate 2011-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-296a21bd77ee4b8ea5a08f9d5603bd122022-12-22T00:18:35ZengFrontiers Media S.A.Frontiers in Genetics1664-80212011-12-01210.3389/fgene.2011.0009618491Characterizing ncRNAs in human pathogenic protists using high-throughput sequencing technologyLesley Joan Collins0Massey UniversityncRNAs are key genes in many human diseases including cancer and viral infection, as well as providing critical functions in pathogenic organisms such as fungi, bacteria, viruses and protists. Until now the identification and characterization of ncRNAs associated with disease has been slow or inaccurate requiring many years of testing to understand complicated RNA and protein gene relationships. High-throughput sequencing now offers the opportunity to characterize miRNAs, siRNAs, snoRNAs and long ncRNAs on a genomic scale making it faster and easier to clarify how these ncRNAs contribute to the disease state. However, this technology is still relatively new, and ncRNA discovery is not an application of high priority for streamlined bioinformatics. Here we summarize background concepts and practical approaches for ncRNA analysis using high-throughput sequencing, and how it relates to understanding human disease. As a case study, we focus on the parasitic protists Giardia lamblia and Trichomonas vaginalis, where large evolutionary distance has meant difficulties in comparing ncRNAs with those from model eukaryotes. A combination of biological, computational and sequencing approaches has enabled easier classification of ncRNA classes such as snoRNAs, but has also aided the identification of novel classes. It is hoped that a higher level of understanding of ncRNA expression and interaction may aid in the development of less harsh treatment for protist-based diseases.http://journal.frontiersin.org/Journal/10.3389/fgene.2011.00096/fullGiardiaTrichomonasmiRNAsiRNAncRNAhigh-throughput sequencing
spellingShingle Lesley Joan Collins
Characterizing ncRNAs in human pathogenic protists using high-throughput sequencing technology
Frontiers in Genetics
Giardia
Trichomonas
miRNA
siRNA
ncRNA
high-throughput sequencing
title Characterizing ncRNAs in human pathogenic protists using high-throughput sequencing technology
title_full Characterizing ncRNAs in human pathogenic protists using high-throughput sequencing technology
title_fullStr Characterizing ncRNAs in human pathogenic protists using high-throughput sequencing technology
title_full_unstemmed Characterizing ncRNAs in human pathogenic protists using high-throughput sequencing technology
title_short Characterizing ncRNAs in human pathogenic protists using high-throughput sequencing technology
title_sort characterizing ncrnas in human pathogenic protists using high throughput sequencing technology
topic Giardia
Trichomonas
miRNA
siRNA
ncRNA
high-throughput sequencing
url http://journal.frontiersin.org/Journal/10.3389/fgene.2011.00096/full
work_keys_str_mv AT lesleyjoancollins characterizingncrnasinhumanpathogenicprotistsusinghighthroughputsequencingtechnology